1-16 of 16
William Clark
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patient-Reported Outcomes of BMT CTN 1703: A Randomized Phase III Study for Gvhd Prophylaxis - a Quality of Life Evaluation

Shernan G. Holtan, Michael J Martens, Monzr M. Al Malki, Yvonne Efebera, Carrie L. Kitko, Ran Reshef, Andrew R. Rezvani, Brian C. Shaffer, Melhem M. Solh, Janny M. Yao, Lyndsey Runaas, Hany Elmariah, Karilyn T. Larkin, Najla H El Jurdi, Mahasweta Gooptu, Alison W Loren, Aric C. Hall, Amin Alousi, Omer Jamy, William Clark, Leslie Kean, Ami S. Bhatt, Miguel-Angel Perales, Kristy Applegate, Juan WU, Eric Liefer, Nancy DiFronzo, Richard J. Jones, Mary M. Horowitz, Deborah Mattila, Mehdi Hamadani, Javier Bolanos-Meade
Journal: Blood
Blood (2023) 142 (Supplement 1): 897.
https://doi.org/10.1182/blood-2023-187859
Published: 2023
Journal Articles

Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both Efficacy and Toxicity: Results of the BMT CTN 1801 Study

Leslie Kean, Steven J Siegel, Joseph T Schmalz, Stephanie A Bien, Danielle Scheffey, Catherine Sanders, Harlan Robins, Kristy Applegate, Merav Bar, Saurabh Chhabra, Sung W. Choi, William Clark, Suman r Das, Robert R. Jenq, Richard J. Jones, John Levine, Brent R. Logan, Hemant S. Murthy, Armin Rashidi, Marcie L. Riches, Wael Saber, Karamjeet S. Sandhu, Anthony D. Sung, Karilyn Larkin, Monzr M. Al Malki, Mahasweta Gooptu, Hany Elmariah, Amin Alousi, Lyndsey Runaas, Brian C. Shaffer, Andrew R. Rezvani, Najla El Jurdi, Alison Loren, Mary M. Horowitz, Javier Bolanos-Meade, Shernan G. Holtan, Ami S. Bhatt, Miguel-Angel Perales, Susan DeWolf
Journal: Blood
Blood (2023) 142 (Supplement 1): 475.
https://doi.org/10.1182/blood-2023-188032
Published: 2023
Journal Articles

Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil As the New Standard for Graft-Versus-Host Disease (GVHD) Prophylaxis in Reduced Intensity Conditioning: Results from Phase III BMT CTN 1703

Shernan G Holtan, Mehdi Hamadani, Juan WU, Monzr M. AL Malki, Lyndsey Runaas, Hany Elmariah, Andrew R. Rezvani, Mahasweta Gooptu, Karilyn T. Larkin, Brian C. Shaffer, Najla H El Jurdi, Alison W. Loren, Melhem Solh, Aric C. Hall, Amin M Alousi, Omer H Jamy, Miguel-Angel Perales, Janny M. Yao, Kristy Applegate, Ami S. Bhatt, Leslie S. Kean, Yvonne A. Efebera, Carrie Lynn Kitko, Ran Reshef, William Clark, Nancy L. DiFronzo, Lori Henderson, Richard J. Jones, Eric Liefer, Michael J Martens, Mary M. Horowitz, Javier Bolanos-Meade
Journal: Blood
Blood (2022) 140 (Supplement 2): LBA-4.
https://doi.org/10.1182/blood-2022-171463
Published: 2022
Journal Articles

MI-Immune/1801: Lessons from an Ongoing, Multi-Center Trial Involving Biospecimen Collection for Prospective Microbiome and Immune Profiling in Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

Erin Brooks, Ashley Spahn, Stephanie Waldvogel, Alan Howard, Merav Bar, Brandi Bratrude, Saurabh Chhabra, William Clark, Suman Ranjan Das, Mary M. Horowitz, Robert R. Jenq, Richard J. Jones, John E. Levine, Brent R. Logan, Hemant S. Murthy, Armin Rashidi, Marcie L. Riches, Mary Mansour Riwes, Karamjeet S. Sandhu, Anthony D. Sung, Monzr M. Al Malki, Lyndsey Runaas, Hany Elmariah, Andrew R. Rezvani, Mahasweta Gooptu, Javier Bolaños-Meade, Shernan G Holtan, Wael Saber, Mehdi Hamadani, Leslie S Kean, Miguel-Angel Perales, Ami S. Bhatt
Journal: Blood
Blood (2021) 138 (Supplement 1): 2955.
https://doi.org/10.1182/blood-2021-149313
Published: 2021
Journal Articles

A Synthetic Lethal Approach to Eradicate AML Via Synergistic Activation of Pro-Apoptotic p53 By MDM2 and BET Inhibitors

Sha Li, Anne-Louise Latif, Ashley Newcombe, Kathryn Gilrory, Neil Robertson, Xue Lei, Darren Finlay, PhD, Karina Barbosa, BSc, Helen Stewart, John Cole, Maria Terradas Terradas, Loveena Rishi Delori, Lynn McGarry, Claire McKeeve, Claire Reid, William Clark, Joana Campos, Kristina Kirschner, Andrew Davis, Jonathan Lopez, Jun-Ichi Sakamaki, Jennifer Morton, Kevin Ryan, Stephen Tait, Sheela Abraham, Tessa L. Holyoake, MD PhD FRCP, FRCPath, Brian Higgins, Xu Huang, BSc, PhD, Karen Blyth, Mhairi Copland, PhD MBBChir, FRCP, FRCPath, Timothy Chevassut, Aniruddha J. Deshpande, PhD, Karen Keeshan, Peter Adams, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14.
https://doi.org/10.1182/blood-2020-143079
Published: 2020
Journal Articles

Transformation from Indolent Primary Cutaneous Marginal Zone Lymphoma to Aggressive Primary Cutaneous Diffuse Large B-Cell Lymphoma: A Rare Case and Review of the Literature

Emily Harris, Ariel Sindel, DO, Ian McConnell, William Clark, MDMS, Alden Chesney, MD, Victor Yazbeck, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5266.
https://doi.org/10.1182/blood-2019-130921
Published: 2019
Journal Articles

Absence of Viral Complications When Using Rituximab to Treat TTP with Plasma Exchange

Gail Rock, PhD MD, Steven Weger, MD, Hana Abouhadjar, MD, David Barth, MD FRCPC, William Clark, MD, Paul R. Yenson, MD FRCPC, Stephen Ronan Foley, MD FRCPC
Journal: Blood
Blood (2015) 126 (23): 2261.
https://doi.org/10.1182/blood.V126.23.2261.2261
Published: 2015
Journal Articles

Dual Inhibition of MDM2 and BET Cooperate to Eradicate Acute Myeloid Leukemia

Anne-Louise Latif, MBChB, John J Cole, Joana Monteiro Campos, William Clark, Lynn McGarry, PhD, Claire Brock, Ashley Newcombe, Karen Keeshan, PhD, Mhairi Copland, BSc (Hons) MB ChB PhDFRCP FRCPath, Peter D Adams, PhD
Journal: Blood
Blood (2015) 126 (23): 674.
https://doi.org/10.1182/blood.V126.23.674.674
Published: 2015
Journal Articles

Favorable Outcomes in Patients with High Donor-Derived T Cell Count Following In Vivo T Cell Depleted Reduced Intensity Allogeneic Stem Cell Transplantation

Amir A Toor, MD, Roy T Sabo, PhD, Harold M Chung, MD, Catherine H Roberts, PhD, Rose H Manjili, BS, Shiyu Song, MD, PhD, David C. Williams, Jr., MD, PhD, William Clark, MD, Masoud H Manjili, DVM, PhD, John M McCarty, MD
Journal: Blood
Blood (2011) 118 (21): 3043.
https://doi.org/10.1182/blood.V118.21.3043.3043
Published: 2011
Journal Articles

Adaptive Immunotherapy In Multiple Myeloma: Epigenetic Modification and Immunomodulation by Sequential Azacitidine and Lenalidomide to Generate Cancer Testis Antigen Specific Cellular Immune Response

Amir A Toor, MD, Kyle Payne, BS, Harold M Chung, MD, Catherine H Roberts, PhD, Roy T Sabo, PhD, Maciej Kmieciak, PhD, William Clark, MD, Christy McLaughlin, BS, Angela Buskey, RN, Jennifer Anderson, RN, Rose H Manjili, BS, Susan D. Roseff, MD, John M McCarty, MD, Masoud H Manjili, DVM, PhD
Journal: Blood
Blood (2011) 118 (21): 2926.
https://doi.org/10.1182/blood.V118.21.2926.2926
Published: 2011
Journal Articles

Genetic Variation In Recipient BAFF Modulates Phenotype of Chronic GvHD After HCT

William Clark, MD, Dana Crawford, Ph.D, Brian Engelhardt, MD, MS, Kristin D. Brown, Fan Kang-Hsien, PhD, Heidi Chen, PhD, Bipin N. Savani, MD, Friedrich Schuening, MD, John P. Greer, MD, Adetola A. Kassim, MD, MS, Madan Jagasia, MD, MS
Journal: Blood
Blood (2010) 116 (21): 215.
https://doi.org/10.1182/blood.V116.21.215.215
Published: 2010
Journal Articles

Distinct Mechanisms of Idiopathic and Thienopyridine-Assocaited Thrombotic Thrombocytopenia Purpura: Final Results from the Surveillance, Epidemiology, and Risk Factors for Thrombotic Thrombocytopenic Purpura (SERF-TTP) Study.

Charles L. Bennett, MD, PhD, MPP, Anaadriana Zakarija, Hau C. Kwaan, MD, PhD, Dilip Pandey, MD, PhD, Paul Yarnold, John F Cursio, MS, Robert Soltysik, MS, Thanh Ha Luu, BA, Elizabeth Richey, BA, Ivy Weiss, BS, June McKoy, MD, MPH, Dennis W Raisch, PhD, RPh, Thomas Raife, MD, Patricia Carey, MD, Ravindra Sarode, MD, Joseph Kiss, MD, Constance Danielson, MD, PhD, Bruce C. McLeod, MD, Thomas L. Ortel, MD, PhD, Jeffery Winters, MD, William Clark, MD, Nicholas Bandarenko, MD, Gail Rock, PhD, MD
Journal: Blood
Blood (2008) 112 (11): 2293.
https://doi.org/10.1182/blood.V112.11.2293.2293
Published: 2008
Journal Articles

ADAMTS-13 Levels Do Not Predict Outcome in Thrombotic Thrombocytopenic Purpura: Protein S Levels Are Maintained during Plasma Exchange with Solvent Detergent Treated Plasma.

Gail A. Rock, Phd, MD, FRCPC, David Anderson, MD, Barrett Benny, MD, David Barth, MD, William Clark, MD, Ronan Foley, MD, David Sutton, MD, Pierre Leblond, MD
Journal: Blood
Blood (2007) 110 (11): 2895.
https://doi.org/10.1182/blood.V110.11.2895.2895
Published: 2007
Journal Articles

Treatment of Thrombotic Thrombocytopenic Purpura Using Solvent Detergent Treated Plasma.

Gail Rock, PhD, MD, FRCP, David Anderson, Barrett Benny, William Clark, Pierre Leblond, David Sutton, Marion Sternbach, George Wells, Members of the Canadian Apheresis Group, Canadian Association of Apheresis Nurses
Journal: Blood
Blood (2005) 106 (11): 3989.
https://doi.org/10.1182/blood.V106.11.3989.3989
Published: 2005
Journal Articles

Hemolytic Uremic Syndrome Is an Immune Mediated Disease: Role of Anti-CD36 Antibodies.

Gail Rock, PhD, MD, William Clark, Marion Sternbach, Maria Kolajova, Peter McLaine
Journal: Blood
Blood (2005) 106 (11): 3990.
https://doi.org/10.1182/blood.V106.11.3990.3990
Published: 2005
Journal Articles

STANDARDIZATION OF THE QUICK PROTHROMBIN TEST : WITH REFERENCE TO THE STATISTICAL SIGNIFICANCE OF VARIATIONS IN THE PROTHROMBIN CONCENTRATION WITH USE OF A STABLE THROMBOPLASTIN OF HIGH POTENCY

PAUL M. AGGELER, M.D., JOAN HOWARD, A.B., S. P. LUCIA, M.D., WILLIAM CLARK, A.B., ALEXIS ASTAFF, D.D.S.
Journal: Blood
Blood (1946) 1 (3): 220–233.
https://doi.org/10.1182/blood.V1.3.220.220
Published: 1946